Elutia Inc (ELUT)

Nov 14, 2024, 8:11 PM EST - 2 months ago

Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript

Oct 23, 2024, 4:05 PM EDT - 3 months ago

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

Sep 18, 2024, 8:00 AM EDT - 4 months ago

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable Devices

Sep 6, 2024, 4:23 PM EDT - 4 months ago

Elutia Celebrates First Year

Sep 5, 2024, 4:05 PM EDT - 4 months ago

Elutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

Sep 3, 2024, 4:05 PM EDT - 4 months ago

Elutia to Participate in Upcoming Investor Conferences

Aug 20, 2024, 7:00 AM EDT - 5 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD EUDA GDTC GOSS GOVX IMRN

Aug 10, 2024, 7:27 AM EDT - 5 months ago

Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 6 months ago

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

Jul 11, 2024, 4:05 PM EDT - 6 months ago

Elutia to Present at the Emerging Growth Conference on Thursday, July 18

Jun 17, 2024, 8:01 AM EDT - 7 months ago

Elutia Announces $13.26 Million Registered Direct Offering

Jun 17, 2024, 8:00 AM EDT - 7 months ago

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

May 12, 2024, 12:21 PM EDT - 8 months ago

Elutia, Inc. (ELUT) Q1 2024 Earnings Call Transcript

Apr 24, 2024, 4:05 PM EDT - 9 months ago

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

Mar 7, 2024, 8:43 PM EST - 11 months ago

Elutia, Inc. (ELUT) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 4:05 PM EST - 11 months ago

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

Feb 22, 2024, 4:05 PM EST - 11 months ago

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

Jan 10, 2024, 4:05 PM EST - 1 year ago

Elutia Regains Compliance with Nasdaq Listing Requirements

Nov 17, 2023, 12:30 PM EST - 1 year ago

Elutia, Inc. (ELUT) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 1 year ago

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results

Nov 9, 2023, 8:30 AM EST - 1 year ago

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

Nov 6, 2023, 4:05 PM EST - 1 year ago

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

Sep 20, 2023, 8:30 AM EDT - 1 year ago

Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference

Sep 19, 2023, 8:36 AM EDT - 1 year ago

Elutia Announces Private Placement for Proceeds Up to $26 Million

Sep 18, 2023, 4:08 PM EDT - 1 year ago

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

Sep 8, 2023, 8:30 AM EDT - 1 year ago

Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 30, 2023, 8:30 AM EDT - 1 year ago

Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures

Aug 20, 2023, 12:41 PM EDT - 1 year ago

Aziyo Biologics, Inc. (AZYO) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 4:05 PM EDT - 1 year ago

Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company

Jul 31, 2023, 4:05 PM EDT - 1 year ago

Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

Jul 13, 2023, 4:30 PM EDT - 1 year ago

Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products

May 19, 2023, 8:15 AM EDT - 1 year ago

Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope

May 14, 2023, 9:32 PM EDT - 1 year ago

Aziyo Biologics, Inc. (AZYO) Q1 2023 Earnings Call Transcript

May 10, 2023, 4:05 PM EDT - 1 year ago

Aziyo Biologics Reports Highest Sales and Gross Profit in Company History

May 3, 2023, 4:05 PM EDT - 1 year ago

Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023

Apr 20, 2023, 4:30 PM EDT - 1 year ago

Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio

Mar 22, 2023, 6:12 PM EDT - 1 year ago

Aziyo Biologics, Inc. (AZYO) Q4 2022 Earnings Call Transcript

Mar 22, 2023, 4:01 PM EDT - 1 year ago

Aziyo Biologics Reports Record Full Year 2022 Revenues

Mar 22, 2023, 8:30 AM EDT - 1 year ago

Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women's Access to Biologics for Soft Tissue Reconstruction

Mar 15, 2023, 4:05 PM EDT - 2 years ago

Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023

Feb 27, 2023, 8:15 AM EST - 2 years ago

Aziyo Biologics to Present at the Cowen 43rd Annual Health Care Conference

Jan 9, 2023, 8:15 AM EST - 2 years ago

Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline Results

Dec 15, 2022, 8:00 AM EST - 2 years ago

Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation

Dec 1, 2022, 9:04 AM EST - 2 years ago

Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock

Nov 30, 2022, 4:08 PM EST - 2 years ago

Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock

Nov 21, 2022, 4:05 PM EST - 2 years ago

Aziyo Biologics to Participate in Upcoming Investor Conferences

Nov 15, 2022, 4:38 PM EST - 2 years ago

Aziyo Biologics, Inc. (AZYO) Q3 2022 Earnings Call Transcript

Nov 14, 2022, 4:01 PM EST - 2 years ago

Aziyo Biologics Reports Strong Third Quarter 2022 Revenue

Nov 9, 2022, 6:00 PM EST - 2 years ago

SWK Holdings Corporation Announces Financial Results for Third Quarter 2022

SWKH

Nov 7, 2022, 4:05 PM EST - 2 years ago

Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022